-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FVs2HFc+l1XabxpcQLN9863NbOZiDKqTawAuY00qus6Ep90jtoEym7ewCa+oL0XA rjPua94KuYmIt+8RUVIBmg== 0000950135-02-003135.txt : 20020627 0000950135-02-003135.hdr.sgml : 20020627 20020627144116 ACCESSION NUMBER: 0000950135-02-003135 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020626 ITEM INFORMATION: Changes in registrant's certifying accountant ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20020627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13738 FILM NUMBER: 02688903 BUSINESS ADDRESS: STREET 1: 1280 MASSACHUSETTS AVENUE STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 6178687455 MAIL ADDRESS: STREET 1: 1280 MASSACHUSETTS AVE STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02138 8-K 1 b43498pce8vk.txt PSYCHEMEDICS CORPORATION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant To Section 13 or 14(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 26, 2002 ------------- PSYCHEMEDICS CORPORATION ------------------------------------------------------ (Exact Name of Registrant As Specified In Its Charter) DELAWARE ---------------------------------------------- (State if Other Jurisdiction of Incorporation) 1-13738 58-1701987 - ------------------------ ------------------------------------ (Commission File Number) (I.R.S. Employer Identification No.) 1280 Massachusetts Ave., Suite 200, Cambridge, MA 02138 - ------------------------------------------------- ---------- (Address of Principal Executive Offices) (Zip Code) (617-868-7455) ---------------------------------------------------- (Registrant's Telephone Number, Including Area Code) N/A ------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT. (a) Information required by Item 304(a)(1) of Regulation S-K. (i) Arthur Andersen LLP was dismissed as the Registrant's independent accountants effective as of the close of business on June 26, 2002. (ii) The reports of Arthur Andersen LLP on the consolidated financial statements of the Registrant at December 31, 2000 and December 31, 2001, and for the three years ended December 31, 2001, contain no adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principle. (iii) The decision to change accountants was recommended by the Audit Committee of the Registrant's Board of Directors, and approved by the full Board of Directors of the Registrant. A new independent public accounting firm has not yet been engaged to act as Psychemedics Corporation's auditors. (iv) In connection with its audits for the two most recent fiscal years and through March 31, 2002, there have been no disagreements with Arthur Andersen LLP on any matter of accounting principle or practice, financial statement disclosure, or auditing scope or procedure, which disagreements if not resolved to the satisfaction of Arthur Andersen LLP would have caused Arthur Andersen LLP to make reference thereto in their report on the financial statements for such years. (v) During the two most recent fiscal years and through March 31, 2002 there have been no reportable events (as defined in Regulation S-K Item 304 (a)(1)(v)). (b) The Registrant has requested that Arthur Andersen LLP provide it with a letter addressed to the SEC stating whether or not it agrees with the above statements. A copy of such letter, dated June 26, 2002, is filed as Exhibit 16 to this form 8-K. Item 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits EXHIBIT NO. DESCRIPTION - ----------- ----------- 16 Letter from Arthur Andersen LLP to the Securities and Exchange Commission dated June 26, 2002. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. PSYCHEMEDICS CORPORATION Dated: June 26, 2002 By: /s/ Peter C. Monson ----------------------------------------- Peter C. Monson, Chief Financial Officer EXHIBIT INDEX EXHIBIT NO. DESCRIPTION - ----------- ----------- 16 Letter from Arthur Andersen LLP to the Securities and Exchange Commission dated June 26, 2002. EX-16 3 b43498pcexv16.txt LETTER FROM ARTHUR ANDERSEN LLP EXHIBIT 16 [Arthur Andersen LLP Letterhead] June 26, 2002 Office of the Chief Accountant Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Dear Sir/Madam: We have read Item 4(a) included in the Form 8-K dated June 26, 2002 of Psychemedics Corporation to be filed with the Securities and Exchange Commission and are in agreement with the statements contained therein. Very truly yours, Arthur Andersen LLP -----END PRIVACY-ENHANCED MESSAGE-----